Cabbacis (OTCQB: CABI) is pioneering harm-reduction in the global tobacco industry, targeting the world’s one billion smokers with its flagship iBlend™ line of reduced-nicotine cigarettes and compatible vaporizer pods. These proprietary, patent protected products combine ultra-low‑nicotine tobacco with non-intoxicating hemp, helping smokers on their nicotine quitting journey. Proven in studies and backed by 35 issued patents worldwide covering the combination of hemp and low-nicotine tobacco in a cigarette, Cabbacis holds a strong IP position ahead of a proposed FDA requirement to lower nicotine levels by 95% in all cigarettes across the United States. To learn more, please visit cabbacis.com.

Cabbacis

Org chart

Teams

Offices